Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Receivables - Net: 2019-2025

Historic Receivables - Net for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $12.7 million.

  • Biodesix's Receivables - Net rose 57.72% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 57.72%. This contributed to the annual value of $8.6 million for FY2024, which is 12.03% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's Receivables - Net is $12.7 million, which was up 70.10% from $7.5 million recorded in Q2 2025.
  • Biodesix's Receivables - Net's 5-year high stood at $18.4 million during Q1 2021, with a 5-year trough of $2.8 million in Q3 2021.
  • For the 3-year period, Biodesix's Receivables - Net averaged around $7.9 million, with its median value being $7.7 million (2023).
  • Per our database at Business Quant, Biodesix's Receivables - Net tumbled by 79.45% in 2022 and then soared by 145.88% in 2024.
  • Quarterly analysis of 5 years shows Biodesix's Receivables - Net stood at $3.7 million in 2021, then spiked by 38.54% to $5.1 million in 2022, then soared by 51.61% to $7.7 million in 2023, then grew by 12.03% to $8.6 million in 2024, then skyrocketed by 57.72% to $12.7 million in 2025.
  • Its last three reported values are $12.7 million in Q3 2025, $7.5 million for Q2 2025, and $7.6 million during Q1 2025.